Resultats de la cerca - Mathieu Virazels
- Mostrar 1 - 1 resultats de 1
-
1
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial per Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pagès, Pascale Olivier, Maha Ayyoub, Muriel Mounier, Amélie Lusque, Stéphanie Brayer, Jean‐Pierre Delord, Nathalie Andrieu‐Abadie, Thierry Levade, Céline Colacios, Bruno Ségui, Nicolás Meyer
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Adverse effect
Cancer
Clinical endpoint
Clinical trial
Cohort
Common Terminology Criteria for Adverse Events
Gastroenterology
Immunotherapy
Infliximab
Internal medicine
Ipilimumab
Medicine
Nivolumab
Oncology
Phases of clinical research
Response Evaluation Criteria in Solid Tumors
Surgery
Tumor necrosis factor alpha